Our clinician-scientists conduct clinical trials and train the next generation of ophthalmologists where patient-centered collaboration improves vision and fuels the development of new therapies. Please click here for a comprehensive list of our ongoing and completed clinical trials.
From studying new experimental drugs to FDA approved devices, our clinicians are at the forefront of clinical research as they continue to enhance the level of care of each patient they see.
See below for the current list of clinical trials at the USC Roski Eye Institute in a wide variety of ophthalmology services. For more information on our clinical trials, call 323-442-6335 or complete our online contact form.
Highlighted Clinical Trials – Completed, Ongoing and Upcoming
- In 2011, the USC Roski Eye Institute conducted the first clinical trials for an experimental therapeutic agent to treat Leber’s Hereditary Optic Neuropathy, a mitochondrial disease.
- In 2014, our institute implanted a programmable micropump smart device, developed by our own USC Roski Eye Institute researchers, that delivers precise small doses of medication into the eye for patients diagnosed with diabetic macular edema, in the first-in-man clinical trial.
- Presently, the first human clinical trials are set to commence, implanting Stem Cells to overcome age-related macular degeneration (AMD). Amir H. Kashani, MD, PhD will be the lead surgeon for the proposed Phase I/IIa clinical trial at USC.
Next, read about our research news.